Pharmacological targets for correction of dyslipidemias. Opportunities and prospects of therapeutic use
VA Kudinov, TS Zakharova, TI Torkhovskaya… - … ), Supplement Series B …, 2018 - Springer
VA Kudinov, TS Zakharova, TI Torkhovskaya, OM Ipatova, AI Archakov
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2018•SpringerThe review summarizes literature data on existing pharmacological agents and novel drug
preparations developed for correction of dyslipidemias and molecular mechanisms of their
action. Much attention is paid to analysis of experimental and clinical studies aimed at
identification of new pharmacological targets for correction of dyslipidemias and
characterization of approaches increasing high density lipoproteins functionality. The
implementation of alternative pharmacological agents with new alternative mechanisms of …
preparations developed for correction of dyslipidemias and molecular mechanisms of their
action. Much attention is paid to analysis of experimental and clinical studies aimed at
identification of new pharmacological targets for correction of dyslipidemias and
characterization of approaches increasing high density lipoproteins functionality. The
implementation of alternative pharmacological agents with new alternative mechanisms of …
Abstract
The review summarizes literature data on existing pharmacological agents and novel drug preparations developed for correction of dyslipidemias and molecular mechanisms of their action. Much attention is paid to analysis of experimental and clinical studies aimed at identification of new pharmacological targets for correction of dyslipidemias and characterization of approaches increasing high density lipoproteins functionality. The implementation of alternative pharmacological agents with new alternative mechanisms of action may improve the effectiveness of traditional treatment in the future.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果